Quality of life of patients with autoimmune diseases submitted to bone marrow transplantation: a longitudinal study.

This study aimed to assess the quality of life of patients with autoimmune diseases (AID) submitted to Bone Marrow Transplantation (BMT) at two different moments: when the patient is admitted at the hospital and at the moment of hospital discharge (30 days after the transplantation). Patients who attended the BMT unit, were older than 18 years, with conditions and availability to voluntarily collaborate to the study were selected. Data were collected through a semi-structured interview and the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36). The sample consisted of 19 patients attended at a university hospital in the interior of São Paulo State, Brazil. The collected data suggest these patients' quality of life is reduced before the realization of the transplantation, followed by a progression in their diseases. Immediately after the transplantation, an improved capacity to perform daily activities is observed, as well as a renewed possibility of making future plans.